Skip to main content
. 2013 Jul 10;136(9):2697–2706. doi: 10.1093/brain/awt188

Table 2.

Comparison of vascular pathology and cerebrovascular disease prevalence in the different groups compared to Alzheimer’s disease

Reference category for analysis Analysed category OR (95% confidence interval) for vascular pathology P-value for vascular pathology OR (95% confidence interval) for cerebrovascular disease P-value for cerebrovascular disease
Alzheimer’s disease FTLD-Tau 0.37 (0.28–0.50) <0.0001 0.38 (0.25–0.57) <0.0001
Alzheimer’s disease FTLD-TDP 0.40 (0.28–0.58) <0.0001 0.20 (0.09–0.42) <0.0001
Alzheimer’s disease Hippocampal sclerosis 1.37 (0.64–2.98) 0.41 1.10 (0.59–2.04) 0.76
Alzheimer’s disease α-Synucleinopathy 0.38 (0.28–0.52) <0.0001 0.47 (0.31–0.70) 0.0002
Alzheimer’s disease Prion disease 0.13 (0.08–0.23) <0.0001 0.24 (0.07–0.83) 0.024
Alzheimer’s disease Unremarkable Brain 0.49 (0.39–0.61) <0.0001
α-Synucleinopathy FTLD-TDP 1.16 (0.71–1.91) 0.56 0.47 (0.19–1.17) 0.11
α-Synucleinopathy FTLD-Tau 0.96 (0.63–1.45) 0.85 0.75 (0.42–1.35) 0.34
FTLD-TDP FTLD-Tau 0.84 (0.53–1.33) 0.46 0.84 (0.53–1.33) 0.46